Search - tctmd.com

Displaying 1 - 20 of 155

Sort: Relevancy | Date

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

News Daily News

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

December 29, 2023

AHA Selects 2023’s Leading Cardiovascular Research

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

December 22, 2023

Reduced EF Evident in Some Elite Endurance Athletes

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

News Daily News

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Michael O'Riordan

December 18, 2023

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

News Daily News

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Yael L. Maxwell

December 15, 2023

Slight Shift Seen After Calories Added to Fast-food Menus

News Daily News

Slight Shift Seen After Calories Added to Fast-food Menus

December 15, 2023

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

News Daily News

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Yael L. Maxwell

December 13, 2023

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

December 12, 2023

Family History of CVD? Low PUFA Intake May Add to Risk

News Daily News

Family History of CVD? Low PUFA Intake May Add to Risk

Michael O'Riordan

December 12, 2023

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

News Daily News

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

December 11, 2023

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

News Daily News

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

December 06, 2023

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

News Daily News

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

December 06, 2023

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

December 2023 Dispatch for the CV Team

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

December 01, 2023

No Adverse CV Effects of COVID-19 Vaccination Seen in Elite US Athletes

News Daily News

No Adverse CV Effects of COVID-19 Vaccination Seen in Elite US Athletes

November 23, 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

November 17, 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

News Conference News AHA 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

November 13, 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

News Conference News AHA 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Michael O'Riordan

November 13, 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH: Heart-1

News Conference News AHA 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

November 12, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.